Back to AKRO

Akero Therapeutics, Inc. 8-K

Accession 0001104659-21-039696

Filing information

CIK
0001744659
Report date
2021-03-22
Filing date
2021-03-22
Form
8-K
Primary document
tm219778d2_8k.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.